Literature DB >> 1571368

Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts.

S Salmon1, C Mazière, M Auclair, L Theron, R Santus, J C Mazière.   

Abstract

Malondialdehyde modification and copper ion-induced autooxidation of the apo E-free HDL3 fraction of high-density lipoproteins were studied with respect to physico-chemical characteristics and physiological properties of the lipoprotein. Cu(2+)-oxidized HDL was much less modified than MDA-treated HDL, in terms of electrophoretic mobility, lipid peroxidation product content, Lys and Trp amino acid residue level and polymerization of apo A-I. With [3H]cholesteryl linoleate-labeled LDL, an inhibition of cholesterol efflux was observed in the presence of modified HDL, with a more marked effect with MDA-modified HDL. Competition studies with iodinated native HDL demonstrated a decreased binding of modified HDL to cell surface receptors. The decrease in cholesterol intracellular content, determined either by the isotopic equilibrium method or by the enzymatic cholesterol oxidase technic, was less marked in the presence of modified HDL than in the presence of native HDL. MDA-modified HDL was the less effective in decreasing cellular cholesterol content. It is thus suggested that malondialdehyde-induced alteration of HDL, or HDL peroxidation, if occurring in vivo, could contribute to the progress of atherogenesis by decreasing cholesterol efflux from peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571368     DOI: 10.1016/0005-2760(92)90050-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.

Authors:  A Cogny; V Atger; J L Paul; T Soni; N Moatti
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

2.  Saccharomyces cerevisiae exhibits a yAP-1-mediated adaptive response to malondialdehyde.

Authors:  H E Turton; I W Dawes; C M Grant
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

3.  Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-α, MMP-9, and MMP-2.

Authors:  V S Soumyarani; N Jayakumari
Journal:  Mol Cell Biochem       Date:  2012-04-17       Impact factor: 3.396

4.  Oxidation-induced loss of the ability of HDL to counteract the inhibitory effect of oxidized LDL on vasorelaxation.

Authors:  Laurence Perségol; Marie-Claude Brindisi; David Rageot; Jean-Paul Pais de Barros; Serge Monier; Bruno Vergès; Laurence Duvillard
Journal:  Heart Vessels       Date:  2014-07-17       Impact factor: 2.037

Review 5.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

6.  Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.

Authors:  Detao Gao; Eugene A Podrez
Journal:  Free Radic Biol Med       Date:  2017-11-15       Impact factor: 7.376

Review 7.  Dysfunctional HDL as a diagnostic and therapeutic target.

Authors:  Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-13       Impact factor: 8.311

8.  Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization, in vivo detection, and functional implications.

Authors:  Detao Gao; Mohammad Z Ashraf; Lifang Zhang; Niladri Kar; Tatiana V Byzova; Eugene A Podrez
Journal:  J Biol Chem       Date:  2020-01-06       Impact factor: 5.157

9.  Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.

Authors:  Linda S May-Zhang; Valery Yermalitsky; Jiansheng Huang; Tiffany Pleasent; Mark S Borja; Michael N Oda; W Gray Jerome; Patricia G Yancey; MacRae F Linton; Sean S Davies
Journal:  J Biol Chem       Date:  2018-04-30       Impact factor: 5.157

10.  Acrolein impairs the cholesterol transport functions of high density lipoproteins.

Authors:  Alexandra C Chadwick; Rebecca L Holme; Yiliang Chen; Michael J Thomas; Mary G Sorci-Thomas; Roy L Silverstein; Kirkwood A Pritchard; Daisy Sahoo
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.